<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <title>CMC Seoul OBY &amp; Breast Pathology - CMC Seoul OBY &amp; Breast Pathology</title>
  <meta name="viewport" content="width=device-width, initial-scale=1">
  
  <link rel="icon" href="https://extraordinary-tulumba-269604.netlify.app/favicon.png">

  
  
  <link rel="stylesheet" href="/css/style.min.6719d72e323121369d5caeb4264b95d8a63cf1deaab029da67602fe5a046e0a4.css">
  

  

</head>

<body class='page page-default-list'>
  <div id="main-menu-mobile" class="main-menu-mobile">
  <ul>
    
    
    <li class="menu-item-home">
      <a href="/">
        <span>Home</span>
      </a>
    </li>
    
    <li class="menu-item-docs active">
      <a href="/docs/">
        <span>Docs</span>
      </a>
    </li>
    
    <li class="menu-item-post">
      <a href="/post/">
        <span>Post</span>
      </a>
    </li>
    
  </ul>
</div>
  <div class="wrapper">
    <div class='header'>
  <div class="container">
    <div class="logo">
      <a href="https://extraordinary-tulumba-269604.netlify.app/"><img alt="Logo" src="/images/logo.svg" /></a>
    </div>
    <div class="logo-mobile">
      <a href="https://extraordinary-tulumba-269604.netlify.app/"><img alt="Logo" src="/images/logo-mobile.svg" /></a>
    </div>
    <div id="main-menu" class="main-menu">
  <ul>
    
    
    <li class="menu-item-home">
      <a href="/">
        <span>Home</span>
      </a>
    </li>
    
    <li class="menu-item-docs active">
      <a href="/docs/">
        <span>Docs</span>
      </a>
    </li>
    
    <li class="menu-item-post">
      <a href="/post/">
        <span>Post</span>
      </a>
    </li>
    
  </ul>
</div>
    <button id="toggle-main-menu-mobile" class="hamburger hamburger--slider" type="button">
  <span class="hamburger-box">
    <span class="hamburger-inner"></span>
  </span>
</button>
  </div>
</div>


    
    
    
    
    
    

    
    <div class="container pt-2 pt-md-6 pb-3 pb-md-6">
      <div class="row">
        <div class="col-12 col-md-3 mb-3">
          <div class="sidebar">
            
<div class="docs-menu">
  <h4>Docs</h4>
  <ul>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-10-18-ki-67/">Ki-67</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-07-18-l1-cell-adhesion-molecule-immunohistochemistry/">L1 cell adhesion molecule Immunohistochemistry</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/2022-06-15-bethesda-interobserver-reproducibility-data/">Bethesda interobserver reproducibility data</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/2022-06-13-nccn-guidelines/">NCCN Guidelines</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-her2-testing-in-breast-cancer-2018-focused-update/">HER2 Testing in Breast Cancer - 2018 Focused Update</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-international-immuno-oncology-biomarker-working-group-on-breast-cancer/">International Immuno-Oncology Biomarker Working Group on Breast Cancer</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-11-lower-anogenital-squamous-terminology-last-for-hpv-associated-lesions/">Lower Anogenital Squamous Terminology (LAST) for HPV-Associated Lesions</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-pd-l1-ihc-22c3-pharmdx-interpretation-manual-triple-negative-breast-cancer-tnbc/">PD-L1 Interpretation Manual</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-10-figo-cancer-report-2021/">FIGO</a>
    </li>
    
    <li class="">
      <a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-cancer-reporting-and-biomarker-reporting-protocols/">Cancer Reporting and Biomarker Reporting Protocols</a>
    </li>
    
  </ul>
</div>

          </div>
        </div>
        <div class="col-12 col-md-9">
          

<span class="overview">Overview</span>
<h1 class="title">CMC Seoul OBY &amp; Breast Pathology</h1>
<div class="content">
  <p>This web site is intended to share data related to OBY &amp; Breast pathology.</p>

</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-10-18-ki-67/">Ki-67</a></h2>
  <p>Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
https://doi.org/10.1093/jnci/djaa201</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-07-18-l1-cell-adhesion-molecule-immunohistochemistry/">L1 cell adhesion molecule Immunohistochemistry</a></h2>
  <p>L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
https://doi.org/10.1016/j.ejca.2014.07.014
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
https://doi.org/10.1038/s41416-018-0187-6</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/2022-06-15-bethesda-interobserver-reproducibility-data/">Bethesda interobserver reproducibility data</a></h2>
  <p>Cytology reporting systemhttps://cytopathology.org/page/ReportingSystems
Bethesda interobserver reproducibility datahttps://bethesda.soc.wisc.edu/index.htm</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/2022-06-13-nccn-guidelines/">NCCN Guidelines</a></h2>
  <p>NCCN Guidelines category 1https://www.nccn.org/guidelines/category_1</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-her2-testing-in-breast-cancer-2018-focused-update/">HER2 Testing in Breast Cancer - 2018 Focused Update</a></h2>
  <p>HER2 Testing in Breast Cancer - 2018 Focused Updatehttps://www.cap.org/protocols-and-guidelines/cap-guidelines/current-cap-guidelines/recommendations-for-human-epidermal-growth-factor-2-testing-in-breast-cancer</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-international-immuno-oncology-biomarker-working-group-on-breast-cancer/">International Immuno-Oncology Biomarker Working Group on Breast Cancer</a></h2>
  <p>International Immuno-Oncology Biomarker Working Group on Breast Cancerhttps://www.tilsinbreastcancer.org</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-11-lower-anogenital-squamous-terminology-last-for-hpv-associated-lesions/">Lower Anogenital Squamous Terminology (LAST) for HPV-Associated Lesions</a></h2>
  <p>CAP guideline Lower Anogenital Squamous Terminology (LAST) for HPV-Associated Lesionshttps://www.cap.org/protocols-and-guidelines/cap-guidelines/current-cap-guidelines/cap-asccp-lower-anogenital-squamous-terminology-for-hpv-associated-lesions</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-pd-l1-ihc-22c3-pharmdx-interpretation-manual-triple-negative-breast-cancer-tnbc/">PD-L1 Interpretation Manual</a></h2>
  <p>VENTANA PD-L1 (SP142) Assay IC staininghttps://diagnostics.roche.com/content/dam/diagnostics/us/en/products/v/ventana-pd-l1-sp142-assay/VENTANA-PD-L1-SP142-Assay-TNBC-IG.pdf
PD-L1 IHC 22C3 pharmDx Interpretation Manual – Triple-Negative Breast Cancerhttps://www.agilent.com/cs/library/usermanuals/public/29389_22c3_pharmdx_tnbc_interpretation_manual_kn355.pdf
PD-L1 IHC 22C3 pharmDx Interpretation Manual – Cervical Cancerhttps://www.agilent.com/cs/library/usermanuals/public/29257_22c3_pharmDx_cervical_interpretation_manual_us.pdf</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-10-figo-cancer-report-2021/">FIGO</a></h2>
  <p>FIGO Cancer Report 2021FIGO staging and reporthttps://www.figo.org/news/figo-cancer-report-2021
</p>
</div>


<div class="summary mb-2">
  
  <h2 class="title-summary"><a href="https://extraordinary-tulumba-269604.netlify.app/docs/breast/2022-06-11-cancer-reporting-and-biomarker-reporting-protocols/">Cancer Reporting and Biomarker Reporting Protocols</a></h2>
  <p>CAP Cancer Reporting and Biomarker Reporting Protocolshttps://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates#protocols</p>
</div>




        </div>
      </div>
    </div>
    
  </div>

  <div class="sub-footer">
  <div class="container">
    <div class="row">
      <div class="col-12">
        <div class="sub-footer-inner">
          <ul>
            <li class="zerostatic"><a href="https://www.zerostatic.io">www.zerostatic.io</a></li>
          </ul>
        </div>
      </div>
    </div>
  </div>
</div>

  

  
  

  
  <script type="text/javascript" src="/js/scripts.min.eaf147370baecdd07c022597db631f99cab1c9cd6479de586f30327a568d6a0f.js"></script>
  

  
  
  
    
  


</body>

</html>
